Neurokinin (NK) 1 Antagonist for Pathological Aggression for Harmful, Impulsive, and Self-/Aggressive Behaviour

NCT02989779 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Aggression

Interventions

DRUG: NK1 Antagonist
DRUG: Placebo Oral Capsule

Sponsor

St. Joseph's Healthcare Hamilton

Collaborators

[object Object]